Improved Visibility of the Subthalamic Nucleus on High-Resolution Stereotactic MR Imaging by Added Susceptibility (T2*) Contrast Using Multiple Gradient Echoes

References

1. ↵
   Richter EO, Hoque T, Halliday W, et al. Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg 2004;100:541–46

   PubMed
2. ↵
   Aziz TZ, Nandi D, Parkin S, et al. Targeting the subthalamic nucleus. Stereotact Funct Neurosurg 2001;77:87–90

   CrossRefPubMed
3. ↵
   Benabid AL, Koudsie A, Benazzouz A, et al. Subthalamic stimulation for Parkinson's disease. Arch Med Res 2000;31:282–89

   CrossRefPubMedWeb of Science
4. ↵
   Dormont D, Ricciardi KG, Tande D, et al. Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 2004;25:1516–23

   Abstract/FREE Full Text
5. ↵
   Slavin KV, Thulborn KR, Wess C, et al. Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 2006;27:80–84

   Abstract/FREE Full Text
6. ↵
   Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr 1986;10:363–68

   PubMedWeb of Science
7. ↵
   Schaltenbrand G, Wahren W. Atlas for Stereotaxy of the Human Brain. Stuttgart, Germany: Thieme;1977
8. ↵
   Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759–67

   PubMedWeb of Science
9. ↵
   Schenck J, Zimmerman E. High field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004;17:433–45

   CrossRefPubMedWeb of Science